27 completed, 10 unknown, 4 recruiting, 1 enrolling by invitation. 22 Not applicable, 8 Phase 2, 3 Phase 1, 2 Phase 3.
Follow Female Sexual Dysfunction: new trials by email Literature Review of Female Sexual Dysfunction trials Research Report on Female Sexual Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessment of Female Sexual Function Index (FSFI) Scores at 1 Month After Endometrial Sampling Performed Under Sedo-Analgesia or Local Anesthesia Female Sexual Dysfunction, Endometrial Sampling | Recruiting | Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization | 210 | 2026-04-15 | 2026-06-05 | |
| At-Home Neuromodulation for Female Sexual Dysfunction Electrical Stimulation, Smart vibrator - Female Sexual Dysfunction | Not applicable | Recruiting | University of Michigan | 24 | 2025-10-15 | 2025-12-23 |
| Supporting Sexual Recovery in Women With Bladder Cancer Qualitative interview/Focus group - Bladder Cancer, Cystectomy | Enrolling by invitation | King's College London | 60 | 2025-08-01 | 2025-08-03 | |
| Late Side-effects After Cervical Cancer Treatment - Prevention and Treatment Pelvic floor muscle training rehabilitation - Pelvic Floor Disorder, Female Pelvic Floor Dysfunction | Not applicable | Completed | St. Olavs Hospital | 25 | 2025-02-04 | 2026-08-21 |
| Female Sexual Dysfunction Assessment and Managment of Vaginismus Botox, Radiofrequency - Female Sexual Dysfunction | Phase 2 / Phase 3 | Not yet recruiting | Assiut University | 40 | 2025-01-01 | 2025-01-01 |
| Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome Onabotulinum toxin A, Conservative management (dietary and behavioral) - Bladder Pain Syndrome, Female Sexual Dysfunction | Recruiting | Walter Reed National Military Medical Center | 159 | 2024-11-01 | 2024-12-11 | |
| Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women with Sexual Arousal Disorder BZ371A 7.5 mg (1.5 ml), BZ371A 5.0 mg (1.0 ml), BZ371A 2.5 mg (0.5 ml) - Female Sexual Arousal Disorder, Female Sexual Dysfunction | Phase 2 | Recruiting | Biozeus Biopharmaceutical S.A. | 30 | 2024-10-01 | 2024-10-22 |
| Evaluation of an Online Intervention for Female Sexual Dysfunction mylovia - Female Sexual Dysfunction | Not applicable | Completed | Gaia AG | 252 | 2024-05-28 | 2025-08-22 |
| Investigation of Awareness Levels of Women Living in Turkey About Kegel Exercises and Pelvic Floor Muscles Female Sexual Dysfunction | Completed | Istanbul Medipol University Hospital | 182 | 2023-10-21 | 2025-11-17 | |
| Investigating the Efficacy of Autologous, Adipose-derived Mesenchymal Stem Cell Therapy for the Treatment of Sexual Function Impairment in Women Aged 40-50 Intravenous administration of Autologous, adipose-derived mesenchymal stem cells - Female Sexual Dysfunction | Phase 1 / Phase 2 | Completed | Vinmec Research Institute of Stem Cell and Gene Technology | 50 | 2023-10-01 | 2026-01-22 |
| the Ameliorating Effects of Antioxidant Gel on Female Arousal Disorder and Sexual Dysfunction Kaempferol - Female Sexual Dysfunction | Phase 1 | Completed | Deraya University | 30 | 2023-09-20 | 2024-05-16 |
| The Effect of Sexual Counseling With the PLISSIT Model on Sexual Function and Sexual Quality of Life in Women With Multiple Sclerosis: A Randomized Controlled Study sexual counselling with PLISSIT model - Multiple Sclerosis, Female Sexual Dysfunction | Not applicable | Unknown | Istanbul University | 86 | 2023-08-01 | 2023-08-22 |
| Vaginal Penetration Alteration Questionnaire Application for the creation of a questionnaire on alterations in vaginal penetration - Female Sexual Dysfunction | Completed | University of Castilla-La Mancha | 150 | 2023-06-01 | 2025-07-23 | |
| Predicting Changes in Core Muscles During Female Sexual Dysfunction: A Comprehensive Analysis Using Machine and Deep Learning no intervention - Female Sexual Dysfunction | Completed | Deraya University | 100 | 2023-02-01 | 2023-09-26 | |
| Effect of Peripheral Neuromodulation on Vaginal Blood Flow - Study 2 Transcutaneous electrical nerve stimulation - Tibial Nerve, Transcutaneous electrical nerve stimulation - Genital Nerve, Neutral and Erotic Film Clip Alternation - Female Sexual Dysfunction, Female Sexual Dysfunction Due to Physical Condition | Not applicable | Completed | University of Michigan | 15 | 2022-09-14 | 2025-07-16 |
| Cognitive-Behavioural & Mindfulness-Based Online Programs for Female Sexual Dysfunction Cognitive-Behavioural Therapy - Online (CBT-O), Mindfulness-Based Therapy - Online (MBT-O) - Female Sexual Dysfunction | Not applicable | Completed | University of British Columbia | 129 | 2021-11-12 | 2025-03-26 |
| LOVE Trial: Limits On Vaginal Intercourse After Mid-urEthral Sling Early restriction release, Standard restriction recommendation - Patient Satisfaction, Female Sexual Dysfunction | Not applicable | Completed | Wake Forest University Health Sciences | 155 | 2021-04-16 | 2025-03-19 |
| Improving Female Sexual Wellness Vibrator - Sexuality, Sexual Dysfunction | Not applicable | Completed | Cedars-Sinai Medical Center | 86 | 2021-04-10 | 2023-04-06 |
| Evaluation of a Novel Female Hygiene Device for Postcoital Discomfort Tampon-like device for absorption of sexual fluids - Vaginal Discharge, Dyspareunia | Not applicable | Unknown | Atlantic Health System | 30 | 2021-04-05 | 2021-05-13 |
| Effect of Peripheral Neuromodulation on Vaginal Blood Flow Transcutaneous electrical nerve stimulation - Tibial Nerve, Transcutaneous electrical nerve stimulation - Genital Nerve - Female Sexual Dysfunction, Spinal Cord Injuries | Not applicable | Completed | University of Michigan | 9 | 2020-11-11 | 2025-11-12 |
Showing 20 of 45. Sign in to see all of them.
Sexual Dysfunction, Physiological (8) · Sexual Dysfunctions, Psychological (5) · Cystitis, Interstitial (3) · Dyspareunia (2) · Multiple Sclerosis (2) · Pelvic Floor Disorders (2) · Sexuality (2) · Spinal Cord Injuries (2) · Urinary Bladder, Overactive (2) · Urinary Incontinence (2) · Carcinoma, Transitional Cell (1) · Coitus (1) · Fecal Incontinence (1) · Hypertension (1) · Metrorrhagia (1)
Urogenital Diseases (17) · Genital Diseases (12) · Female Urogenital Diseases (11) · Female Urogenital Diseases and Pregnancy Complications (11) · Male Urogenital Diseases (9) · Pathological Conditions, Signs and Symptoms (7) · Behavior (6) · Mental Disorders (6) · Signs and Symptoms (6) · Urologic Diseases (6) · Genital Diseases, Female (5) · Urinary Bladder Diseases (5) · Lower Urinary Tract Symptoms (4) · Sexual Behavior (4) · Urological Manifestations (4)
1-((1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidin-3-yl)carbonyl)-3,5-dimethyl-4-phenylpiperidin-4-ol (1) · Arginine (1) · Botulinum Toxins, Type A (1) · Cholinergic Antagonists (1) · Conservative Treatment (1) · Diet (1) · Electric Stimulation (1) · Focus Groups (1) · Hormonal Contraception (1) · Metoprolol (1) · Nebivolol (1) · Niacinamide (1) · Oxytocin (1) · Petrolatum (1) · Transcutaneous Electric Nerve Stimulation (1)
University of Michigan (3) · Deraya University (2) · Acerus Pharmaceuticals Corporation (1) · Assiut University (1) · Atlantic Health System (1) · Beni-Suef University (1) · Biozeus Biopharmaceutical S.A. (1) · Cedars-Sinai Medical Center (1) · Chulalongkorn University (1) · East Coast Institute for Research (1) · East Suburban Ob Gyn (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · GTO Pharmaceutical, LLC (1) · Gaia AG (1) · Istanbul Medipol University Hospital (1)
United States (21) · Egypt (4) · Turkey (Türkiye) (4) · Brazil (2) · Canada (2) · Norway (2) · Spain (2) · Vietnam (2) · Austria (1) · Denmark (1) · Germany (1) · Russia (1) · Sweden (1) · Taiwan (1) · Thailand (1)
Becky Lynn, MD (1) · Benjamin Epstein, PharmD (1) · Catherine A Matthews, MD (1) · Christine M Vaccaro, DO (1) · Daniil G. Nemenov, MD (1) · Edmund C Baracat, Head (1) · Jason Kim, MD (1) · Josep Combalia, MD (1) · Karyn Eilber, MD (1) · Kyle Stephenson, PhD (1) · Liem Thanh Nguyen, PhD (1) · Lila Nachtigall, M.D. (1) · Lori Brotto, PhD (1)
PMID 12626215, PMID 18948180, PMID 24773615, PMID 25914334, PMID 26151620, PMID 26631095, PMID 28189292, PMID 28899827, PMID 38303661, PMID 39704322, PMID 40132194, PMID 41634129
K23AG052628 (1)